Blockchain Registration Transaction Record
Kairos Pharma Provides Update on Clinical Trials and Strategic Developments
Kairos Pharma provides an update on its clinical trials and strategic developments, highlighting advancements in oncology therapeutics. Learn more about ENV105, KROS101, and the company's financial position.

This news matters as it sheds light on Kairos Pharma's advancements in oncology therapeutics, particularly its progress with ENV105 and KROS101 in combating drug resistance and immune suppression in cancer. Investors, healthcare professionals, and patients interested in innovative cancer treatments should take note of Kairos Pharma's promising developments and strong financial standing.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0xadd71b5bf624d88ed7d95653a0e4ebb0fcd49673b7ec256bc6d96d7fcc71c346 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | kiwioOlU-11b56ea13aefbdbb4f9964a47b9b4772 |